Current perspectives on ophthalmic manifestations of childhood rheumatic diseases

Current Rheumatology Reports

Volumn 15, Issue 7, 2013, Pages

  Palejwala, Neal V ^a   Yeh, Steven ^a   Angeles Han, Sheila T ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CHILDREN'S HEALTHCARE OF ATLANTA   (United States)

Author keywords

Behcet's disease; Biologic; Childhood; Eye; HLA B27; Juvenile idiopathic arthritis; Juvenile spondyloarthropathy; Ophthalmology; Pediatrics; Rheumatic diseases; Spondyloarthropathy; Systemic lupus erythematosus; Treatment; Uveitis

Indexed keywords

ADALIMUMAB; CHLOROQUINE; CORTICOSTEROID; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; BIOLOGICAL PRODUCT; GLUCOCORTICOID;

ADVERSE OUTCOME; ANCA ASSOCIATED VASCULITIS; ARTICLE; AUTOIMMUNE DISEASE; BEHCET DISEASE; CATARACT; CHILDHOOD DISEASE; CILIARY BODY DYSFUNCTION; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG EFFICACY; EYE DISEASE; EYE TOXICITY; HUMAN; HYPOPYON; INTERMEDIATE UVEITIS; JUVENILE RHEUMATOID ARTHRITIS; KERATOPATHY; MUCOCUTANEOUS LYMPH NODE SYNDROME; OUTCOME ASSESSMENT; QUALITY OF LIFE; REACTIVE ARTHRITIS; RETINA MACULOPATHY; RHEUMATIC DISEASE; SARCOIDOSIS; SJOEGREN SYNDROME; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT INDICATION; UVEITIS; ARTHRITIS; CHILD; REVIEW; COMPLICATION;

ARTHRITIS; BIOLOGICAL PRODUCTS; CHILD; GLUCOCORTICOIDS; HUMANS; RHEUMATIC DISEASES; UVEITIS;

EID: 84877786741     PISSN: 15233774     EISSN: 15346307     Source Type: Journal    
DOI: 10.1007/s11926-013-0341-3     Document Type: Article

References (130)

1. Reiff A. Ocular complications of childhood rheumatic diseases: Nonuveitic inflammatory eye diseases. Current Rheumatology Reports. 2009;11:226-32.
2. Cunningham Jr ET. Uveitis in children. Ocul Immunol Inflamm. 2000;8:251-61. (Pubitemid 32174746)
3. Zierhut M, Michels H, Stubiger N, et al. Uveitis in children. Int Ophthalmol Clin. 2005;45:135-56. (Pubitemid 40570758)
4. Ravelli A, Martini A. Juvenile idiopathic arthritis. Lancet. 2007;369(9563):767-78.
5. Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31:390-2. (Pubitemid 38160763)
6. Foster CS. Diagnosis and treatment of juvenile idiopathic arthritis-associated uveitis. Curr Opin Ophthalmol. 2003;14:395-8. (Pubitemid 38333579)
7. Saurenmann RK, Levin AV, Feldman BM, et al. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: A long-term follow-up study. Arthritis & Rheumatism. 2007;56(2):647-57.
8. Oren B, Sehgal A, Simon JW, et al. The prevalence of uveitis in juvenile rheumatoid arthritis. J AAPOS. 2001;5:2-4. (Pubitemid 33619780)
9. Aggarwal A, Misra R. Juvenile chronic arthritis in India: is it different from that seen in Western countries? Rhumatol Int. 1994;14:53-6. (Pubitemid 24256822)
10. • Qian Y, Acharya NR. Juvenile idiopathic arthritis-associated uveitis. Current Opinion in Ophthalmology. 2010;21:468-72. This article nicely summarizes the recent literature about JIA-uveitis.
11. Dana MR, Merayo-Lloves J, Schaumberg DA, Foster CS. Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology. 1997;104:236-44. (Pubitemid 27088098)
12. de Boer J, Wulffraat N, Rothova A. Visual loss in uveitis of childhood. Br J Ophthalmol. 2003;87:879-84. (Pubitemid 36765255)
13. Thorne JE, Woreta F, Kedhar SR, et al. Juvenile idiopathic arthritis-associated uveitis: Incidence of ocular complications and visual acuity loss. Am J Ophthalmol. 2007;143(5):840-46. (Pubitemid 46601385)
14. Hoeve M, Ayuso VK, Schalij-Delfos NE, et al. The clinical course of juvenile idiopathic arthritis-associated uveitis in childhood and puberty. Br J Ophthalmol. 2012;96:852-56.
15. Sabri K, Saurenmann RK, Silverman ED. Course, complications, and outcome of juvenile arthritis-related uveitis. Journal of AAPOS. 2008;12(6):539-45.
16. Marvillet I, Terrada C, Quartier P, et al. Ocular threat in juvenile idiopathic arthritis. Joint Bone Spine. 2009;76:383-88.
17. Gregory AC, Kempen JH, Daniel EB. Risk factors for loss of visual acuity among patients with uveitis associated with juvenile idiopathic arthritis: The systemic immunosuppressive therapy for eye diseases study. Ophthalmology. 2013;120:186-92.
18. Woreta F, Thorne JE, Jabs DA, et al. Risk factors for ocular complications and poor visual acuity at presentation among patients with uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2007;143:647-55. (Pubitemid 46452508)
19. Section on Rheumatology and Section on Ophthalmology. Guidelines for ophthalmologic examination in children with juvenile rheumatoid arthritis. Pediatrics. 1993;92(2):295-6.
20. Angeles-Han ST, Griffin KW, Harrison MJ, et al. Development of a vision-related quality of life instrument for children age 8-18 years for use in juvenile idiopathic arthritis-associated uveitis. Arthritis and Rheumatism. 2011;63(9):1254-61.
21. Paroli MP, Spinucci G, Fabiani C, Pivetti-Pezzi P. Retinal complications of juvenile idiopathic arthritis-related uveitis: a microperimetry and optical coherence tomography study. Ocul Immunol Inflamm. 2010;18(1):54-9.
22. Edelsten C, Lee V, Bentley CR, et al. An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol. 2002;86:51-6. (Pubitemid 34074885)
23. Ayuso VK, ten Cate HAT, van der Does P, et al. Male gender as a risk factor for complications in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol. 2010;149:994-9.
24. Cabral DA, Petty RE, Malleson PN, et al.: Visual prognosis in children with chronic anterior uveitis and arthritis. J Rheumatol 21:2370-2375
25. Hofer M, Southwood TR. Classification of childhood arthritis. Best Prac Res Clin Rheumatol. 2002;16:379-96.
26. Horneff G, Burgos-Vargas R. Juvenile idiopathic arthritis. Sub-group characteristics and comparisons between rheumatoid arthritis-like subgroups and ankylosing spondylitis-like subgroups. Clin Exp Rheumatol. 2009;27:S131-8.
27. • Scofield RH, Sestak AL. Juvenile spondyloarthropathies. Curr Rheumatol Rep. 2012;14:395-401. This article summarizes the current literature on juvenile spondyloarthropathies.
28. Stoll ML, Bhore R, Dempsy-Robertson M, Punaro M. Spondyloarthritis in a pediatric population: Risk factors for sacroiliitis. J Rheumatol. 2010;37(11):2402-8.
29. Ozgocmen S, Ardicoglu O, Kamanli A. Pattern of Disease Onset, Diagnostic Delay, and Clinical Features in Juvenile Onset and Adult Onset Ankylosing Spondylitis. J Rheumatol. 2009;36:2830-3.
30. Liao CH, Huang JL. Juvenile ankylosing spondilitis with uveitis. Asian Pacific Journal of Allergy and Immunology. 2003;21:69-71.
31. Silva-Ramírez B, Vargas-Alarcón G, Granados J, Burgos-Vargas R. HLA antigens and juvenile onset spondyloarthritides: negative association with non-B27 alleles. Clin Exp Rheumatol. 2005;23(5):721-3. (Pubitemid 41300722)
32. Dougados M, Baeten D. Spondyloarthritis. Lancet. 2011;377:2127-37.
33. Kollnberger S, Bird LA, Roddis M, et al. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J Immunol. 2004;173:1699-710. (Pubitemid 38971601)
34. Mear JP, Schreiber KL, Münz C, et al. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J Immunol. 1999;163:6665-70.
35. Cokington CD, Han DP. Bilateral nongranulomatous uveitis and a post-streptococcal syndrome. Am J Ophthalmol. 1991;112(5):595-6.
36. Rehman S, Anand S, Reddy A, et al. Post streptococcal syndrome uveitis: a descriptive case series and literature review. Ophthalmology. 2006;113(4):701-6.
37. Nataneli N, Aguilera ZP, Rosenbaum PS, et al. Poststreptococcal keratouveitis associated with group C streptococcus pharyngitis. Clinical Ophthalmology. 2011;5:1257-59.
38. Ansell B. Reactive arthritis/Reiter's syndrome in children. Clin Exp Rheumatol. 1994;12:581-82.
39. Keat A. Reiter's syndrome and reactive arthritis in perspective. N Engl J Med. 1988;309:1606-15.
40. Manimegalai N, Rajamurugan A, Rajendran P, et al. Childhood reactive arthritis. J Clin Rheumatol. 2008;14(5):292-93.
41. Singsen B, Bernstein B, Koster-King K, Glovsky M, Hansen V. Reiter's syndrome in childhood. Arthritis Rheum. 1977;20(Suppl):402-7.
42. Tinley C, Van Zyl L, Grötte R. Poststreptococcal syndrome uveitis in South African children. Br J Ophthalmol. 2012;96(1):87-9.
43. Kiss S, Letko E, Qamruddin S, Baltatzis S, Foster S. Ocular Manifestions of Reiter's Syndrome. Ophthalmology. 2003;110:1764-69. (Pubitemid 37025436)
44. Smith JA, Mackensen F, Sen HN, et al. Epidemiology and course of disease in childhood uveitis. Ophthalmology. 2009 Aug;116(8):1544-51.
45. Nikkhah H, Ramezani A, Ahmadieh H, et al. Childhood pars planitis; clinical features and outcomes. J Ophthalmic Vis Res. 2011;6(4):249-54.
46. Donaldson MJ, Pulido JS, Herman DC, Diehl N, Hodge D. Pars planitis: A 20-year study of incidence, clinical features, and outcomes. Am J Ophthalmol. 2007;144:812-7. (Pubitemid 350122366)
47. Raja SC, Jabs DA, Dunn JP, et al. Pars planitis: clinical features and class II HLA association. Ophthalmology. 1999;106:594-9. (Pubitemid 30191598)
48. Arellans-Garcia L, Navarro-Lopez LP, Recillas- Gispert C. Pars planitis in the Mexican Mestizo population: ocular findings, treatment, and visual outcome. Ocul Immunol Inflamm. 2003;11:53-60. (Pubitemid 36918645)
49. Romero R, Peralta J, Sendagorta E, Abelairas J. Pars planitis in children: epidemiologic, clinical and therapeutic characteristics. J Pediatr Ophthalmol Strabismus. 2007;44:288-93. (Pubitemid 47572004)
50. Guest S, Funkhouser E, Lightman S. Pars planitis: a comparison of childhood onset and adult onset disease. Clinical and Experimental Ophthalmology. 2001;29:81-4. (Pubitemid 32396473)
51. Cimaz R, Ansell BM. Sarcoidosis in the pediatric age. Clin Exp Rheumatol. 2002;20:231-7. (Pubitemid 34413707)
52. Choi DE, Birnbaum AD, Oh F, Tessler HH, Goldstein DA. Pediatric uveitis secondary to probable, presumed, and biopsy-proven sarcoidosis. J Pediatr Ophthalmol Strabismus. 2011;48(3):157-62.
53. Hoffmann AL, Milman N, Byg KE. Childhood sarcoidosis in Denmark 1979-1994: incidence, clinical features and laboratory results at presentation in 48 children. Acta Paediatr. 2004;93:30-6. (Pubitemid 38134717)
54. Shetty AK, Gedalia A. Childhood sarcoidosis: a rare but fascinating disorder. Pediatr Rheumatol Online. 2008;6:6. (Pubitemid 351832971)
55. Shetty AK, Gedalia A. Sarcoidosis: a pediatric perspective. Clin Pediatr (Phila). 1998;37:707-17.
56. Kataria S, Trevathan GE, Holland JE, Kataria YP. Ocular presentation of sarcoidosis in children. Clin Pediatr (Phila). 1983;22:793-7. (Pubitemid 14244028)
57. Pattishall EN, Kendig Jr EL. Sarcoidosis in children. Pediatr Pulmonol. 1996;22:195-203. (Pubitemid 26343908)
58. James DG, Neville E, Langley DA. Ocular sarcoidosis. Trans Ophthalmol Soc UK. 1976;96:133-9. (Pubitemid 8052481)
59. Khalatbari D, Stinnett S, McCallum RM, Jaffe GJ. Demographic-related variations in posterior segment ocular sarcoidosis. Ophthalmology. 2004;111:357-62. (Pubitemid 38183245)
60. Yanardag H, Pamuk ON. Lacrimal gland involvement in sarcoidosis: the clinical features of 9 patients. Swiss Med Wkly. 2003;133:388-91. (Pubitemid 37087126)
61. Habibi S, Saleem MA, Ramanan AV. Juvenile systemic lupus erythematosus: review of clinical features and management. Indian Pediatrics. 2011;48:879-86.
62. Brunner HI, Feldman BM, Bombardier C, Silverman ED. Sensitivity of the Systemic Lupus Erythematosus Disease Activity Index, British Isles Lupus Assessment Group Index, and Systemic Lupus Activity Measure in the evaluation of clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum. 1999;42:1354-60. (Pubitemid 30265592)
63. Guiterrez-Suarez R, Ruperto N, Gastaldi R, et al. A proposal for a pediatric version of the systemic lupus international collaborating clinics/American college of Rheumatology damage index based on the on analysis of 1,015 patients with juvenile-onset systemic lupus erthematosus. Arthritis & Rheumatism. 2006;54(9):2989-96. (Pubitemid 44497780)
64. Brunner HI, Gladman DD. Ibañez D, Urowitz MD, Silverman ED: Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 2008;58:556-62. (Pubitemid 351294890)
65. Font J, Cervera R, Espinosa G, et al. Systemic lupus erythematosus (SLE) in childhood: analysis of clinical and immunological findings in 34 patients and comparison with SLE characteristics in adults.
66. Almeida RT, Aikawa NE, Sallum AME, et al. Irreversible blindness in juvenile systemic lupus erythematosus. Lupus. 2011;20:95-7.
67. Avcin T, Silverman ED. Review: Antiphospholipid antibodies in pediatric systemic lupus erythematosus and the antiphospholipid syndrome. Lupus. 2007;16:627-33. (Pubitemid 47359999)
68. Montehermoso A, Cervera R, Font J, et al. Association of antiphopholipid antibodies with retinal vascular disease in systemic lupus erythematosus. Sem Arth Rheum. 1999;28(5):326-32. (Pubitemid 29211376)
69. Hannouche D, et al. Systemic lupus erythematosus with choroidopathy and serous retinal detachment. Int Ophthalmol. 1995;19:125-27.
70. Schwartz M, Roberts J. Membranous and vascular choroidopathy: two patterns of immune deposits in systemic lupus erythematosus. Clin Immunol Immunopathol. 1983;29:369-80. (Pubitemid 14240256)
71. Matsuo T, et al. Multifocal pigment epithelial damages with serous retinal detachment in systemic lupus erythematosus. Ophthalmologica. 1987;195:97-102.
72. • Palejwala NV, Walia HS, Yeh S. Ocular manifestations of systemic lupus erythematosus: A review of the literature. Autoimmune Dis. 2012. This review summarizes the ocular complications that are commonly seen in systemic lupus erythematosus.
73. Soylu M, Ozdemir G, Anli A. Pediatric uveitis in Southern Turkey. Ocul Immunol Inflamm. 1997;5:197-202. (Pubitemid 27445569)
74. Mochizuki M, Akduman L, Nussenblatt RB. Behcet's disease. In: Pepose JS, Holland GN, Wilhelmus KR, editors. Ocular infection and immunity. St Louis: Mosby; 1996. p. 663-75.
75. Fujikawa S, Suesmitus T. Behcet disease in children: A nationwide retrospective survery in Japan. Acta Paediatrica Japonica. 1997;39:285-89.
76. Tugal-Tutkun I, Urgancioglu M. Childhood-onset uveitis in Behcet disease: A descriptive study of 36 cases. Am J Ophthalmol. 2003;136(6):1114-19. (Pubitemid 37485779)
77. Koné-Paut I, Yurdakul S, Bahabri SA, et al. Clinical features of Behcet's disease in children: an international collaborative study of 86 cases. J Pediatr. 1998;132:721-5. (Pubitemid 28194599)
78. Kitaichi N, Miyazaki A, Stanford MR, Iwata D, Chams H, Ohno S. Low prevalence of juvenile-onset Behçet's disease with uveitis in East/South Asian people. Br J Ophthalmol. 2009;93(11):1428-30.
79. Atmaca L, Boyvat A, Yalcindag N, et al. Behcet disease in children. Ocular Immunology & Inflammation. 2011;19(2):103-7.
80. Colvard DM, Robertson DM, O'Duffy JD. The ocular manifestations of Behcet's disease. Arch Ophthalmol. 1977;95:1813-15.
81. Citirik M, Berker N, Songur MS. Ocular findings in childhood-onset Behcet disease. J AAPOS. 2009;13:291-95.
82. Pivetti-Pezzi P, Accorinti M, Abdulaziz MA, La Cava M, Torella M, Riso D. Behcet's disease in children. Jpn J Ophthalmol. 1995;39:309-14.
83. Kesen MR, Goldstein DA, Tessler HH. Uveitis associated with pediatric Behcet disease in the American Midwest. Am J Ophthalmol. 2008;146:819-27.
84. Tugal-Tutkun I, Onal S, Altan-Yaycioglu R, Altunbas H, Urgancioglu M. Uveitis in Behcet disease: An analysis of 880 patients. Am J Ophthalmol. 2004;138:373-80. (Pubitemid 39208563)
85. Falk RJ, Gross WL, Guillevin L, et al. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Arthritis Rheum. 2011;63:863-4.
86. Cabral DA, Uribe AG, Benseler S, et al. Classification, presentation, and initial treatment of Wegener's granulomatosis in childhood. Arthritis Rheum. 2009;60(11):3413-24.
87. Vanoni F, Bettinelli A, Keller F, et al. Vasculitides associated with IgG antineutrophil cytoplasmic autoantibodies in childhood. Pediatr Nephrol. 2010;25:205-12.
88. Schmidt J, Pulido JS, Matteson EL. Ocular manifestations of systemic disease: antineutrophil cytoplasmic antibody-associated vasculitis. Curr Opin Ophthalmol. 2011;22:489-95.
89. Jiang B, Zhao YY, Wei SH. Granulomatosis with polyangiitis: The relationship between ocular and nasal disease. Ocul Immunol Inflamm. 2012 [Epub].
90. Vischio JA, McCrary CT. Orbital Wegener's granulomatosis: a case report and review of the literature. Clin Rheumatol. 2008;27(10):1333-6.
91. Shiboski SC, Shiboski CH, Criswell LA, et al. American college of rheumatology classification criteria for Sjogren's syndrome: A data-driven expert consensus approach in the Sjogren's international collaborative clinical alliance cohort. 2012; 64(4): 475-87
92. Hernández-Molina G, Avila-Casado C, Cárdenas- Velázquez F, et al. Similarities and differences between primary and secondary Sjögren's syndrome. J Rheumatol. 2010;37(4):800-8.
93. Civilibal M, Canpolat N, Yurt A. A child with primary Sjogren Syndrome and a review of the literature. Clinical Pediatrics. 2007;46(8):738-42. (Pubitemid 47366770)
94. Cimaz R, Casadei A, Rose C, et al. Primary Sjogren syndrome in the paediatric age: a multicentre survey. Eur J Pediatr. 2003;162(10):661-65. (Pubitemid 37255495)
95. Houghton K, Malleson P, Cabral D, Petty R, Tucker L. Primary Sjogren's syndrome in children and adolescents: are proposed diagnostic criteria applicable. J Rheumatol. 2005;32:2225-32. (Pubitemid 41587872)
96. Bartunkova J, Sediva A, Vencovsky J, Tesar V. Primary Sjogren's syndrome in children and adolescents: proposal for diagnostic criteria. Clin Exp Rheumatol. 1999;17:381-6. (Pubitemid 29265691)
97. Stiller M, Golder W, Döring E, et al. Primary and secondary Sjögren's syndrome in children-a comparative study. Clin Oral Investig. 2000;4(3):176-82.
98. Nakamura Y, Yashiro M, Uehara R, et al. Epidemiologic features of Kawasaki disease in Japan: results of the 2007-2008 nationwide survey. J Epidemiol. 2010;20(4):302-07.
99. Lin YT, Manlhiot C, Ching JC, et al. Repeated systemic surveillance of Kawasaki disease in Ontario from 1995 to 2006. Pediatr Int. 2010;52:699-706.
100. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and long-term management of Kawasaki disease. Circulation. 2004;110:2747-71. (Pubitemid 39453026)
101. Burke MJ, Rennebohm RM. Eye involvement in Kawasaki disease. J Pediatr Ophthalmol Strabismus. 1981;18:7-11. (Pubitemid 11026910)
102. Kadyan A, Choi J, Headon MP. Disciform keratitis and optic disc swelling in Kawasaki disease: an unusual presentation. Eye. 2006;20(8):976-7. (Pubitemid 44210213)
103. Burns JC, Joffe L, Sargent RA, Glode MP. Anterior uveitis associated with Kawasaki syndrome. Pediatr Infect Dis. 1985;4:258-61. (Pubitemid 15093168)
104. Rennebohm RM, Burke MJ, Crowe W, et al. Anterior uveitis in Kawasaki's disease. Am J Ophthalmol. 1981;91(4):535-37. (Pubitemid 11106431)
105. Burke MJ, Rennebohm RM. Eye involvement in Kawasaki disease. J Pediatr Ophthalmol Strabismus. 1981;18(5):7-11. (Pubitemid 11026910)
106. Farvardin M, Kashef S, Aleyasin S, et al. Sudden unilateral blindness in a girl with Kawasaki disease. J Pediatr Ophthalmol Strabismus. 2007;44:303-04. (Pubitemid 47572007)
107. Grouteau E, Dubuisson C, Brochard K, et al. Severe global inflammatory involvement of ocular segments and optic disc swelling in a 12 year-old girl with Kawasaki disease. Eur J Ophthalmol. 2011;21:112-14.
108. Garweg JG, Suter C, Aebi-Ochsner. Macular oedema in Kawasaki syndrome. Gaefes Arch Clin Exp Ophthalmol. 2012;250:1101-04.
109. Newton R. Molecular mechanisms of glucocorticoid action: what is important? Thorax. 2000;55:603-13. (Pubitemid 30398277)
110. • Thorne JE, Woreta FA, Dunn JP, Jabs DA. Risk of cataract development among children with juvenile-idiopathic arthritis uveitis treated with topical corticosteroids. Ophthalmology. 2010;117:1436-41. This retrospective cohort study showed that >3 drops of topical corticosteroids was associated with a significantly increased risk of cataract formation.
111. Romero R, Peralta J, Sendagorta E, Abelairas J. Pars planitis in children: epidemiologic, clinical and therapeutic characteristics. J Pediatr Ophthalmol Strabismus. 2007;44(5):288-93. (Pubitemid 47572004)
112. Beukelman T, Ringold S, Davis TE, et al. CARRA Registry Investigators. Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: A cross-sectional analysis of the CARRA Registry. J Rheumatol. 2012;39(9):1867-74.
113. Schatz CS, Uzel JL, Leininger L, et al. Immunosuppressants used in a steroid-sparing strategy for childhood uveitis. J Pediatr Ophthalmol Strabismus. 2007;44(1):28-34. (Pubitemid 46279978)
114. Smith JR, Levinson RD, Holland GN, et al. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum. 2001;45:252-7. (Pubitemid 32952905)
115. Saurenmann RK, Levin AV, Rose JB, et al. Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology (Oxford). 2006;45(8):982-9. (Pubitemid 44283053)
116. Foeldvari I, Nielsen S, Kümmerle-Deschner J, et al. Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. J Rheumatol. 2007;34(5):1146-50. (Pubitemid 46774863)
117. Kahn P, Weiss M, Imundo LF, Levy DM. Favorable response to high-dose infliximab for refractory childhood uveitis. Ophthalmology. 2006;113(5):860-4.
118. • Zannin ME, Birolo C, Gerloni VM, et al. Safety and efficacy of infliximab and adalimumab for refractory uveitis in juvenile idiopathic arthritis: 1-year followup data from the Italian Registry. J Rheumatol. 2013;40(1):74-9. Infliximab and adalimumab appear to be effective and safe for the treatment of refractory uveitis.
119. Tynjälä P, Kotaniemi K, Lindahl P, et al. Adalimumab in juvenile idiopathic arthritis-associated chronic anterior uveitis. Rheumatology (Oxford). 2008;47(3):339-44. (Pubitemid 351267203)
120. Reiff A, Takei S, Sadeghi S, et al. Etanercept therapy in children with treatment-resistant uveitis. Arthritis Rheum. 2001;44(6):1411-5. (Pubitemid 32537541)
121. Schmeling H, Horneff G. Etanercept and uveitis in patients with juvenile idiopathic arthritis. Rheumatology (Oxford). 2005;44(8):1008-11. (Pubitemid 41487173)
122. Taban M, Dupps WJ, Mandell B, et al. Etanercept (enbrel)-associated in- flammatory eye disease: case report and review of the literature. Ocul Immunol Inflamm. 2006;14:145-50. (Pubitemid 43890770)
123. Angeles-Han S, Flynn T, Lehman T. Abatacept for refractory juvenile idiopathic arthritis-associated uveitis- a case report. J Rheumatol. 2008;35(9):1897-8.
124. William M, Faez S, Papaliodis GN, Lobo AM. Golimumab for the treatment of refractory juvenile idiopathic arthritis-associated uveitis. J Ophthalmic Inflamm Infect. 2012;2(4):231-3.
125. Sen HN, Levy-Clarke G, Faia LJ, et al. High-dose daclizumab for the treatment of juvenile idiopathic arthritis-associated active anterior uveitis. Am J Ophthalmol. 2009;148(5):696-703.
126. Ziering CL, Rabinowitz LG, Esterly NB. Antimalarials for children: Indications, toxicities, and guidelines. J Am Acad Dermatol. 1993;28:764-70. (Pubitemid 23133389)
127. Marmor MF, Kellner U, Lai TYY, Lyons JS, Mieler WF. Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology. 2011;118(2):415-22.
128. American College of Rheumatology: Screening for hydroxychloroquine retinopathy. Available at: https://www.rheumatology.org/practice/clinical/ position/hydroxyp2.pdf. Accessed February 2013.
129. • Angeles-Han ST, Griffin KW, Harrison MJ, et al. Development of a vision-related quality of life instrument for children ages 8-18 years for use in juvenile idiopathic arthritis-associated uveitis. Arthritis Care Res (Hoboken). 2011;63(9):1254-61. This study provides evidence of the validity and reliability of the EYE-Q in the measurement of VRQOL.
130. Angeles-Han ST, Griffin KW, Lehman TJ, et al. The importance of visual function in the quality of life of children with uveitis. J AAPOS. Mar 15 2010.